このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Theta-Burst-Stimulation in Recurrent Stroke Recovery

2019年11月25日 更新者:Christian Grefkes、University Hospital of Cologne
The present study aims at investigating the effects of intermittent theta-burst stimulation (iTBS) for motor recovery in recurrent stroke patients. Therefore a daily intervention of repetitive transcranial magnetic stimulation over 8 days combined with subsequent physiotherapy is compared to a control condition, sham stimulation combined with subsequent physiotherapy. Motor function, degree of disability and quality of life are examined in order to evaluate the effects of iTBS in the rehabilitation of recurrent stroke patients in the first weeks and after three months.

調査の概要

詳細な説明

To date, the majority of neuromodulation approaches aiming at improving motor recovery after stroke are limited to patients with first-ever ischemic stroke. Therefore, rehabilitation of recurrent stroke mainly includes physiotherapy and occupational therapy. Yet, particular these patients retain movement impairment relevant for activities of daily living.

By using repetitive transcranial magnetic stimulation (rTMS), it is possible to promote recovery of connectivity between brain regions, particularly after stroke and thereby improve motor performance. Previous data indicate that intermittent theta-burst stimulation (iTBS), a protocol of neuromodulation, enhances the effects of subsequent motor training in early rehabilitation after stroke.

The current study aims at investigating whether daily repetitive transcranial magnetic stimulation over 8 days combined with subsequent physiotherapy leads to better motor recovery in recurrent stroke, compared to control condition, physiotherapy after sham stimulation. Motor function, degree of disability and quality of life are examined in order to evaluate the effects of iTBS in the rehabilitation of recurrent stroke patients in the first weeks and after three months.

研究の種類

介入

入学 (予想される)

60

段階

  • フェーズ2

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Cologne、ドイツ、50937
        • Christian Grefkles

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

40年~90年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • written consent
  • age: 40-90 years
  • recurrent stroke
  • hemiparesis with impaired hand motor function

Exclusion Criteria:

  • Subjects who are legally detained in an official institute (§20 MPG)
  • Electronic implants or ferromagnetic Implants located in the head, neck or thorax (e.g. clips, intracranial shunt, artificial heart valve, pacemaker)
  • Medication pump (e.g. insulin pump)
  • Metal splinters in eye or head
  • Pregnancy / breastfeeding
  • Severe Neurodegenerative disease
  • Severe Neuroinflammatory disease
  • History of seizures / epilepsy
  • Physical addiction to alcohol, medication, or drugs (excluded: nicotine)
  • Insufficient compliance
  • Present or past malignant tumor involving the central nervous system
  • Severe Psychiatric disease
  • Frequent medication with benzodiazepines, high-potency antipsychotics or tricyclic antidepressants before hospitalization or long-term during hospitalization

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:基礎科学
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Real-iTBS
Intermittent theta-burst-stimulation (iTBS) protocol
Sham stimulation
偽コンパレータ:Sham-iTBS
Intermittent theta-burst-stimulation (iTBS) protocol
Sham stimulation

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Relative grip force
時間枠:3 months after enrollment
grip force as measured with vigorimeter
3 months after enrollment

二次結果の測定

結果測定
メジャーの説明
時間枠
Relative grip force
時間枠:After 8 days of intervention, and 3 months of enrollment
Grip force as measured with vigorimeter
After 8 days of intervention, and 3 months of enrollment
Motor function
時間枠:After 8 days of intervention, and 3 months of enrollment
Action Research Arm Test, ARAT
After 8 days of intervention, and 3 months of enrollment
Motor function
時間枠:After 8 days of intervention, and 3 months of enrollment

Fugl-Meyer Motor Scale of the upper extremity, FM The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully.

Minimum score in upper limb = 0 Maximum score in upper limb = 66, Subscales are summed

After 8 days of intervention, and 3 months of enrollment
Stroke severity
時間枠:After 8 days of intervention, and 3 months of enrollment

National Instituts of Health Stroke Scale, NIHSS The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.

The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0.

After 8 days of intervention, and 3 months of enrollment
Degree of disability
時間枠:After 8 days of intervention, and 3 months of enrollment
Modified Rankin Scale, mRS The scale runs from 0-6, running from perfect health (0) without symptoms to death (6).
After 8 days of intervention, and 3 months of enrollment
Motor cortex excitability/ Motor evoked potential
時間枠:After 8 days of intervention, and 3 months of enrollment
Motor evoked potential (MEP) induced by stimulation of the affected motor cortex
After 8 days of intervention, and 3 months of enrollment
Motor cortex excitability/ Resting motor threshold
時間枠:After 8 days of intervention, and 3 months of enrollment
Resting motor threshold as measured by stimulation of the affected motor cortex, RMT
After 8 days of intervention, and 3 months of enrollment
Motor cortex excitability/ Short-interval intracortical inhibition
時間枠:After 8 days of intervention, and 3 months of enrollment
Short-interval intracortical inhibition Short-interval intracortical inhibition (SICI) is a widely used paired-pulse transcranial magnetic stimulation (TMS) measure to assess inhibition in human motor cortex
After 8 days of intervention, and 3 months of enrollment
Motor cortex excitability/ Ipsilateral silent period
時間枠:After 8 days of intervention, and 3 months of enrollment
Ipsilateral silent period The ipsilateral silent period (iSP) is supposed to be a specific marker of transcallosal motor inhibition. Measured by a short attenuation or interruption of ongoing voluntary electromyographic (EMG) activity in hand muscles induced by focal TMS of the ipsilateral M1.
After 8 days of intervention, and 3 months of enrollment
Quality of life
時間枠:After 8 days of intervention, and 3 months of enrollment
EuroQol 5D questionnaire, EQ-5D
After 8 days of intervention, and 3 months of enrollment
Activities of daily living at admission and discharge in external rehabilitation facility
時間枠:After 8 days of intervention, and 3 months of enrollment
Barthel-Index (BI) scores as documented by external rehabilitation facility The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). A higher number is associated with a greater likelihood of being able to live at home with a degree of independence following discharge from hospital. The scale yield a score of 0-100.
After 8 days of intervention, and 3 months of enrollment
Days of rehabilitation after intervention phase
時間枠:3 months after enrollment
Days of rehabilitation after intervention phase as documented by external rehabilitation facility
3 months after enrollment

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Christian Grefkes, MD、University Hospital Cologne

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2018年1月11日

一次修了 (予想される)

2021年11月1日

研究の完了 (予想される)

2021年11月1日

試験登録日

最初に提出

2017年11月3日

QC基準を満たした最初の提出物

2017年11月6日

最初の投稿 (実際)

2017年11月9日

学習記録の更新

投稿された最後の更新 (実際)

2019年11月27日

QC基準を満たした最後の更新が送信されました

2019年11月25日

最終確認日

2019年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

Magstim Super Rapid2 Systemの臨床試験

購読する